title: Fatal liver injury associated with rifampin-pyrazinamide treatment of latent tuberculosis infection.
authors.forename: Kenneth G
authors.initials: KG
authors.lastname: Castro
authors.forename: John A
authors.initials: JA
authors.lastname: Jereb
authors.forename: Venkatarama Rao
authors.initials: VR
authors.lastname: Koppaka
authors.forename: David L
authors.initials: DL
authors.lastname: Cohn
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems; D000995:Antitubercular Agents / Q000009:adverse effects*; D002487:Centers for Disease Control and Prevention, U.S.; D004359:Drug Therapy, Combination; D006801:Humans; D017093:Liver Failure / Q000139:chemically induced* / Q000453:epidemiology; D011718:Pyrazinamide / Q000009:adverse effects*; D012293:Rifampin / Q000009:adverse effects*; D014376:Tuberculosis / Q000188:drug therapy*; D014481:United States / Q000453:epidemiology
chemical_list: D000995:Antitubercular Agents; D011718:Pyrazinamide; D012293:Rifampin